Eiichi Ogawa

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Reply to "Concerns Regarding the Paradoxical Renal Outcomes in Patients Switching From Entecavir to Tenofovir Alafenamide".

Reply to "Concerns Regarding the Paradoxical Renal Outcomes in Patients Switching From Entecavir to Tenofovir Alafenamide".

Journal: Journal of gastroenterology and hepatology

Published: December 23, 2025

Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosis.

Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosis.

Journal: The American journal of gastroenterology

Published: October 13, 2025

Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

Journal: The American journal of gastroenterology

Published: October 13, 2025

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 25, 2025

Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.

Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.

Journal: Journal of gastroenterology and hepatology

Published: May 21, 2025

Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Journal: Gut

Published: February 07, 2025

Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Journal: Alimentary pharmacology & therapeutics

Published: February 05, 2025

Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.

Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.

Journal: Journal of gastroenterology and hepatology

Published: November 06, 2024

Blowin' in the Wind: Air Pollution and the Risk of Hepatocellular Carcinoma.

Blowin' in the Wind: Air Pollution and the Risk of Hepatocellular Carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2024

Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study.

Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study.

Journal: Atherosclerosis plus

Published: July 09, 2024

Editorial: Retreatment of direct-acting antiviral failures with the current first-line regimens for patients with chronic hepatitis C.

Editorial: Retreatment of direct-acting antiviral failures with the current first-line regimens for patients with chronic hepatitis C.

Journal: Alimentary pharmacology & therapeutics

Published: June 17, 2024

Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.

Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.

Journal: Journal of clinical and translational hepatology

Published: March 07, 2024

Showing 1-12 of 131

Last Updated: 09/26/2026